{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:14:51Z","timestamp":1789719291321,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejmech.2014.07.038","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T09:17:35Z","timestamp":1405070255000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi"],"prefix":"10.1016","volume":"84","author":[{"given":"Sangmi","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungbum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunju","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongseon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghyun","family":"Goo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair L.","family":"Siqueira-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio H.","family":"Freitas-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.07.038_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2014.07.038_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JCM.02029-06","article-title":"Molecular diagnosis of leishmaniasis: current status and future applications","volume":"45","author":"Reithinger","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0163-4453(94)91059-6","article-title":"Visceral leishmaniasis: more prevalent and more problematic","volume":"29","author":"Baily","year":"1994","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.ejmech.2014.07.038_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.038_bib7","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"P\u00e9rez-Victoria","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.038_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jac\/dkp357","article-title":"Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis","volume":"64","author":"P\u00e9rez-Molina","year":"2009","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2014.07.038_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-0-387-77570-8_9","article-title":"DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy","volume":"625","author":"Das","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/138161208784041051","article-title":"Kinetoplast as a potential chemotherapeutic target of trypanosomatids","volume":"14","author":"Motta","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2014.07.038_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1515\/BC.2003.062","article-title":"The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania","volume":"384","author":"Krauth-Siegel","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2014.07.038_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib13","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania","volume":"52","author":"Cavalli","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.038_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00436-004-1223-4","article-title":"The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure","volume":"94","author":"Cavalcanti","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2014.07.038_bib15","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm101439s","article-title":"Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei","volume":"55","author":"Hiltensperger","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.038_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bmcl.2006.11.090","article-title":"Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening","volume":"17","author":"Holloway","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.07.038_bib17","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.01568-08","article-title":"Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity","volume":"53","author":"Holloway","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.038_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio837","article-title":"Drug discovery and development for neglected parasitic diseases","volume":"2","author":"Renslo","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2014.07.038_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2014.07.038_bib21","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1371\/journal.pntd.0001671","article-title":"An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani Amastigotes in human","volume":"6","author":"Siqueira-Neto","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2014.07.038_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1248\/cpb.37.962","article-title":"Syntheses of the metabolites of 1-(2-ethoxyehtyl)-2-(hexahydro-4-methyl-1 H-1,4-diazepin-1-yl)-1H-benzimidazole difumarate (KG-2413) and related compounds","volume":"37","author":"Iemura","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2014.07.038_bib23","unstructured":"B. Buckman, J.B. Nicholas, L. Beigelman, V. Serebryany, A.D. Stoycheva, T. Thrailkill, S.D. Seiwert, Cyclic peptide inhibitors of hepatitis C virus replication, PCT Int. Appl. (2011). WO2011038293."},{"key":"10.1016\/j.ejmech.2014.07.038_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11094-006-0105-8","article-title":"Synthesis and biological activity of N-acylmethyl derivatives of 9H-2,3-dihydroimidazo- and 10H-2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazoles and their reduction products","volume":"40","author":"Anisimova","year":"2006","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2014.07.038_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1134\/S1070428010020223","article-title":"Research in the field of imidazo[1,2-a]benzimidazole derivatives: XXVII. 1-Acylmethyl-2-(\u03c9-hydroxyalkylamino)benzimidazoles and their transformation into derivatives of tricyclic systems","volume":"46","author":"Anisimova","year":"2010","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2014.07.038_bib26","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drug for activity against Trypanosoma cruzi using parasites expressing \u03b2-galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.038_bib27","doi-asserted-by":"crossref","first-page":"e87188","DOI":"10.1371\/journal.pone.0087188","article-title":"An image-based algorithm for precise and accurate high throughput assessment of drug activity against the human parasite Trypanosoma cruzi","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2014.07.038_bib28","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1371\/journal.pntd.0000675","article-title":"Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds","volume":"4","author":"Siqueira-Neto","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2014.07.038_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400645X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400645X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T18:36:46Z","timestamp":1565635006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341400645X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":29,"alternative-id":["S022352341400645X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.038","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}